Dr. Cristofaro joined the National Cancer Institute’s (NCI’s) Division of Cancer Treatment and Diagnosis (DCTD) in 2007 after completing a two-year Presidential Management Fellowship. During his tenure, Dr. Cristofaro’s work has focused on implementing intellectual property policy and agreement negotiation to support DCTD’s core function of advancing the development of novel anticancer therapeutic agents, with a particular focus on enabling innovative public-private partnerships. Dr. Cristofaro currently serves as Intellectual Property Program Manager for the DCTD and as Alternate Technology Development Coordinator for the NCI. He received his Ph.D. in Microbiology from the University of Maryland and his J.D. from Georgetown University.